Interstitial lung disease in sclerodermaWHITE, Barbara.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, viii, 371-390 [21 p.]Article

SclerodermaWHITE, Barbara.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, 250 p.Serial Issue

Observations sur l'inégalité professionnelle dans l'économie informelle = Observations on occupational inequality in informal economyHARRISS-WHITE, Barbara.Revue internationale du travail. 2003, Vol 142, Num 4, pp 1-2, issn 0378-5599, 13 p.Article

Musculoskeletal involvement in sclerodermaPOPE, Janet E.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, viii, 391-408 [14 p.]Article

Systemic sclerosis: the susceptible host (genetics and environment)TAN, Filemon K.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, v, 211-237 [13 p.]Article

Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-beingMEDSGER, Thomas A.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, vi, 255-273 [20 p.]Article

Scleroderma renal crisisSTEEN, Virginia D.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, vii, 315-333 [20 p.]Article

Scleroderma epidemiologyMAYES, Maureen D.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, issn 0889-857X, v, 239-254 [17 p.]Article

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical TrialsFELSON, David T; SMOLEN, Josef S; BROOKS, Peter et al.Arthritis and rheumatism. 2011, Vol 63, Num 3, pp 573-586, issn 0004-3591, 14 p.Article

Safety Profile and Clinical Outcomes in a Phase I, Placebo-Controlled Study of Siplizumab in Acute Graft-Versus-Host DiseaseADKINS, Douglas; RATANATHARATHORN, Voravit; YANG, Harry et al.Transplantation. 2009, Vol 88, Num 2, pp 198-202, issn 0041-1337, 5 p.Article

High-dose versus low-dose d-penicillamine in early diffuse systemic sclerosis trial: Lessons learnedCLEMENTS, Philip J; SEIBOLD, James R; STEEN, Virginia et al.Seminars in arthritis and rheumatism. 2004, Vol 33, Num 4, pp 249-263, issn 0049-0172, 15 p.Article

Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisLIN, Antony T. H; CLEMENTS, Philip J; FURST, Daniel E et al.Rheumatic diseases clinics of North America. 2003, Vol 29, Num 2, pp viii-ix, issn 0889-857X, 30 p.Article

Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenonMERKEL, Peter A; HERLYN, Karen; ROTHFIELD, Naomi F et al.Arthritis and rheumatism. 2002, Vol 46, Num 9, pp 2410-2420, issn 0004-3591, 11 p.Article

Neutralization of Interferon-α/β―Inducible Genes and Downstream Effect in a Phase I Trial of an Anti―Interferon-α Monoclonal Antibody in Systemic Lupus ErythematosusYIHONG YAO; RICHMAN, Laura; JALLAL, Bahija et al.Arthritis and rheumatism. 2009, Vol 60, Num 6, pp 1785-1796, issn 0004-3591, 12 p.Article

Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical responseHARAOUI, Boulos; CAMERON, Louise; OUELLET, Michèle et al.Journal of rheumatology. 2006, Vol 33, Num 1, pp 31-36, issn 0315-162X, 6 p.Article

Cyclophosphamide versus placebo in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.The New England journal of medicine. 2006, Vol 354, Num 25, pp 2655-2666, issn 0028-4793, 12 p.Article

Long-term experience with etanercept in the treatment of rheumatoid arthritis in elderly and younger patients : Patient-reported outcomes from multiple controlled and open-label extension studiesSCHIFF, Michael H; YU, Elaine B; WEINBLATT, Michael E et al.Drugs & aging. 2006, Vol 23, Num 2, pp 167-178, issn 1170-229X, 12 p.Article

Cas contre personne : Hiérarchie ou identité = Case vs. person: Hierarchy or identityTSEDRYK, Yahor.Revue québécoise de linguistique. 2002, Vol 31, Num 2, issn 0710-0167, 19, 109-135 [28 p.]Article

Pulmonary T cell repertoire in patients with graft-versus-host disease following blood and marrow transplantationYUROVSKY, Vladimir V; COTTLER-FOX, Michele H; ATAMAS, Sergei P et al.American journal of hematology. 2001, Vol 66, Num 1, pp 1-11, issn 0361-8609Article

Skin thickness score as a predictor and correlate of outcome in systemic sclerosis: High-dose versus low-dose penicillamine trialCLEMENTS, Philip J; HURWITZ, Eric L; MEDSGER, Thomas A et al.Arthritis and rheumatism. 2000, Vol 43, Num 11, pp 2445-2454, issn 0004-3591Article

Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human studyBURMESTER, Gerd R; FEIST, Eugen; SLEEMAN, Matthew A et al.Annals of the rheumatic diseases. 2011, Vol 70, Num 9, pp 1542-1549, issn 0003-4967, 8 p.Article

Use of type I interferon-inducible mRNAs as pharmacodynamic markers and potential diagnostic markers in trials with sifalimumab, an anti-IFNα antibody, in systemic lupus erythematosusYIHONG YAO; HIGGS, Brandon W; RICHMAN, Laura et al.Arthritis research & therapy (Print). 2010, Vol 12, issn 1478-6354, S6.1-S6.7, SUP1Article

Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumabBISSONNETTE, Robert; LANGLEY, Richard G; PAPP, Kim et al.Archives of dermatological research (Print). 2009, Vol 301, Num 6, pp 429-442, issn 0340-3696, 14 p.Article

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung diseaseTASHKIN, Donald P; ELASHOFF, Robert; SEIBOLD, James R et al.American journal of respiratory and critical care medicine. 2007, Vol 176, Num 10, pp 1026-1034, issn 1073-449X, 9 p.Article

Impact of oral cyclophosphamide on health-related quality of life in patients with active scleroderma lung disease : Results from the scleroderma lung studyKHANNA, Dinesh; XIAOHONG YAN; RILEY, David J et al.Arthritis and rheumatism. 2007, Vol 56, Num 5, pp 1676-1684, issn 0004-3591, 9 p.Article